Press releases

Explore the latest updates and breakthroughs in our research, showcasing key milestones and innovations that are advancing the fields of reproductive medicine and women’s health

All Media

October 05, 2026

FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026

Lausanne, Switzerland and Copenhagen, Denmark, October 05, 2026 – ReproNovo today announced that Fierce Biotech has named it as one of 2026’s Fierce 15 biotechnology companies. The distinction recognizes ReproNovo as one of the most innovative and promising private biotechnology companies in the industry.

July 06, 2026

REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION

Lausanne, Switzerland and Copenhagen, Denmark, July 06, 2026 – ReproNovo, a clinical-stage biopharmaceutical company committed to addressing critical gaps in male and female fertility as well as women’s health, today announced that the first participant has been dosed in the Company’s EU Phase 2 clinical trial of RPN-002, entitled Nolasiban…

March 20, 2026

REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD

Lausanne, Switzerland and Copenhagen, Denmark, March 20, 2026 – ReproNovo, a clinical-stage biopharmaceutical company committed to addressing critical gaps in male and female fertility as well as women’s health, today announced the appointment of Mark Altmeyer as Chairman of the Board of Directors.

Connect with ReproNovo

Join us on our journey of innovation and collaboration.
Find out where you can meet us next.

All Meetups

November 02, 2026 – November 04, 2026

13th China Healthcare Summit

Shanghai

November 09, 2026 – November 11, 2026

BIO-Europe Cologne

Cologne

November 17, 2026 – November 20, 2026

Jeffries Global Healthcare Conference

London